RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Targeting OCT2 to ameliorate cisplatin‐induced ototoxicity in zebrafish and mice

      한글로보기

      https://www.riss.kr/link?id=O112978071

      • 저자
      • 발행기관
      • 학술지명
      • 권호사항
      • 발행연도

        2020년

      • 작성언어

        -

      • Print ISSN

        0892-6638

      • Online ISSN

        1530-6860

      • 등재정보

        SCI;SCIE;SCOPUS

      • 자료형태

        학술저널

      • 수록면

        1-1   [※수록면이 p5 이하이면, Review, Columns, Editor's Note, Abstract 등일 경우가 있습니다.]

      • 구독기관
        • 전북대학교 중앙도서관  
        • 성균관대학교 중앙학술정보관  
        • 부산대학교 중앙도서관  
        • 전남대학교 중앙도서관  
        • 제주대학교 중앙도서관  
        • 중앙대학교 서울캠퍼스 중앙도서관  
        • 인천대학교 학산도서관  
        • 숙명여자대학교 중앙도서관  
        • 서강대학교 로욜라중앙도서관  
        • 충남대학교 중앙도서관  
        • 한양대학교 백남학술정보관  
        • 이화여자대학교 중앙도서관  
        • 고려대학교 도서관  
      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The organic cation transporter OCT2 is expressed in renal tubular cells, dorsal root ganglia, and outer hair cells, where it regulates uptake of xenobiotic substrates such as the widely used anticancer drug, cisplatin. We previously reported that various tyrosine kinase inhibitors (TKIs) with YES1‐kinase inhibitory ability, including dasatinib, can potently reduce OCT2 function (Sprowl et al, Nat Commun 2016). Against this background, we here explored the utility of zebrafish (Danio rerio), compared with mice, as in vivo screening tools to identify effective modulators of OCT2‐dependent, debilitating side effect associated with cisplatin treatment, such as ototoxicity (hearing loss).
      In vitro uptake studies were performed with HeLa cells expressing human OCT2, mouse Oct2 or the single zebrafish OCT (zfOct) with high genomic similarity to mammalian OCTs. HEK293T cells were used for transfection of mutated zfOct using different substrates (ASP+, cisplatin) with or without inhibitors. In vivo studies were done in ABxLF zebrafish (5 dpf) and wild‐type or OCT2‐deficient mice on an FVB background. Cisplatin‐induced hearing loss in zebrafish was evaluated by hair cell death in the lateral line after treatment with YO‐PRO1, and rheotaxis movement was captured by video camera. Auditory brainstem responses (8, 16, 32 kHz) were measured to assess hearing loss associated with cisplatin (10 mg/kg, i.p.) in mice with and without dasatinib (15 mg/kg, p.o.) pretreatment.
      A comparative in vitro screen of OCT2 and zfOct using the prototypical fluorescent substrate ASP showed that both transporters could be inhibited by the same TKIs, including dasatinib (63.6% vs 66.5%) and nilotinib (53.6% vs 68.8%), with comparable IC50 values. Hela cells expressing OCT2 or zfOct accumulated cisplatin by >2‐fold compared to control cells, and these processes were sensitive to inhibition by the same TKIs (inhibition from 40 to 100% of the uptake). Tyr to Phe mutagenesis in zfOct at previously confirmed YES1‐regulated tyrosine phosphorylation sites in OCT2 was associated with impaired transport function. In addition, silencing YES1 expression with siRNA impaired zfOct function, suggesting that a similar regulatory mechanism exists for both the mammalian and zebrafish transporters. In vivo, neuromasts, consisting of receptive hair cells, accumulated OCT2/zfOct specific substrates such as ASP+, and this process could be inhibited by pretreatment with cisplatin (100 μM, 6‐h pre‐incubation) or dasatinib (10 μM, 6 h). In addition, cisplatin treatment was associated with a disruption of neuromast‐related control of hearing and balance, as determined from a seeker response assay. In mice, pretreatment with dasatinib protected against cisplatin‐induced high frequency hearing loss in a manner similar to that observed in OCT2‐deficient mice.
      These studies provide new insights into the regulatory mechanism and role of OCT2 in cisplatin‐induced toxicities in zebrafish and mice, and support the further translational exploration of OCT2 inhibitors as a preventative strategy to ameliorate a debilitating toxicity associated with a commonly used chemotherapeutic agent.
      번역하기

      The organic cation transporter OCT2 is expressed in renal tubular cells, dorsal root ganglia, and outer hair cells, where it regulates uptake of xenobiotic substrates such as the widely used anticancer drug, cisplatin. We previously reported that vari...

      The organic cation transporter OCT2 is expressed in renal tubular cells, dorsal root ganglia, and outer hair cells, where it regulates uptake of xenobiotic substrates such as the widely used anticancer drug, cisplatin. We previously reported that various tyrosine kinase inhibitors (TKIs) with YES1‐kinase inhibitory ability, including dasatinib, can potently reduce OCT2 function (Sprowl et al, Nat Commun 2016). Against this background, we here explored the utility of zebrafish (Danio rerio), compared with mice, as in vivo screening tools to identify effective modulators of OCT2‐dependent, debilitating side effect associated with cisplatin treatment, such as ototoxicity (hearing loss).
      In vitro uptake studies were performed with HeLa cells expressing human OCT2, mouse Oct2 or the single zebrafish OCT (zfOct) with high genomic similarity to mammalian OCTs. HEK293T cells were used for transfection of mutated zfOct using different substrates (ASP+, cisplatin) with or without inhibitors. In vivo studies were done in ABxLF zebrafish (5 dpf) and wild‐type or OCT2‐deficient mice on an FVB background. Cisplatin‐induced hearing loss in zebrafish was evaluated by hair cell death in the lateral line after treatment with YO‐PRO1, and rheotaxis movement was captured by video camera. Auditory brainstem responses (8, 16, 32 kHz) were measured to assess hearing loss associated with cisplatin (10 mg/kg, i.p.) in mice with and without dasatinib (15 mg/kg, p.o.) pretreatment.
      A comparative in vitro screen of OCT2 and zfOct using the prototypical fluorescent substrate ASP showed that both transporters could be inhibited by the same TKIs, including dasatinib (63.6% vs 66.5%) and nilotinib (53.6% vs 68.8%), with comparable IC50 values. Hela cells expressing OCT2 or zfOct accumulated cisplatin by >2‐fold compared to control cells, and these processes were sensitive to inhibition by the same TKIs (inhibition from 40 to 100% of the uptake). Tyr to Phe mutagenesis in zfOct at previously confirmed YES1‐regulated tyrosine phosphorylation sites in OCT2 was associated with impaired transport function. In addition, silencing YES1 expression with siRNA impaired zfOct function, suggesting that a similar regulatory mechanism exists for both the mammalian and zebrafish transporters. In vivo, neuromasts, consisting of receptive hair cells, accumulated OCT2/zfOct specific substrates such as ASP+, and this process could be inhibited by pretreatment with cisplatin (100 μM, 6‐h pre‐incubation) or dasatinib (10 μM, 6 h). In addition, cisplatin treatment was associated with a disruption of neuromast‐related control of hearing and balance, as determined from a seeker response assay. In mice, pretreatment with dasatinib protected against cisplatin‐induced high frequency hearing loss in a manner similar to that observed in OCT2‐deficient mice.
      These studies provide new insights into the regulatory mechanism and role of OCT2 in cisplatin‐induced toxicities in zebrafish and mice, and support the further translational exploration of OCT2 inhibitors as a preventative strategy to ameliorate a debilitating toxicity associated with a commonly used chemotherapeutic agent.

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼